Health
Pfizer CEO reveals 2030 growth plan as company faces up to $18 billion revenue hit from generics
Pfizer CEO Albert Bourla talks during a press conference with European Commission President after a visit to oversee the production of the Pfizer-BioNtech Covid-19 vaccine at the factory of US pharmaceutical company Pfizer, in Puurs, on April 23, 2021. John Thys | AFP | Getty Images Pfizer CEO Albert Bourla laid out his plan Tuesday […]
Read More
Pfizer raises 2022 earnings guidance, beats third-quarter expectations
Vials containing the Pfizer/BioNtech vaccine against the coronavirus disease (COVID-19) are displayed before being used at a mobile vaccine clinic, in Valparaiso, Chile, January 3, 2022. Rodrigo Garrido | Reuters Pfizer on Tuesday raised its 2022 earnings guidance after booking a strong third quarter that beat Wall Street expectations. Pfizer now expects earnings per share […]
Read More
Pfizer RSV vaccine given to pregnant mothers is effective at protecting newborns, company’s data shows
Pfizer’s vaccine against respiratory syncytial virus, or RSV, is highly effective at protecting newborns when the shot is given to the mothers late in their pregnancy, according to clinical trial data published Tuesday. RSV is a common respiratory virus that generally causes mild cold-like symptoms, but it can be dangerous for infants younger than 6 […]
Read More
Long Covid is affecting women more than men, national survey finds
A woman receives a dose of a vaccine against the coronavirus disease (COVID-19) at a sport stadium during the coronavirus disease pandemic, in Vina del Mar, Chile, April 22, 2021. Rodrigo Garrido | Reuters Long Covid is more common among women than men, according to federal data. More than 17% of women have had long […]
Read More
Omicron subvariants resistant to key antibody treatments are increasing every week in the U.S.
Two omicron subvariants that are resistant to key antibody treatments are on the rise in the U.S., according to data from the Centers for Disease Control and Prevention. The subvariants BQ.1 and BQ.1.1 now represent 27% of infections in the U.S., a significant jump from the week prior when they made up about 16% of […]
Read More
Multiple revenue misses in one of our winners convinced us to take profits and get out
We never like to sell on a down day. But after an iffy quarter, we decided to exit. Source
Read More
We’re exiting a drug stock for a nice gain and putting some of that money to work elsewhere
Traders work on the floor of the New York Stock Exchange (NYSE) on October 27, 2022 in New York City. Stocks continued their upward gains Thursday with the Dow rising nearly 400 points following a new GDP report that beat expectations. Spencer Platt | Getty Images Source
Read More
Covid cases, controls spread in China
Covid cases and controls have increased in China this month. Pictured here on Oct. 27, 2022, is a neighborhood in Shanghai that’s been fenced in for Covid control. Future Publishing | Future Publishing | Getty Images BEIJING — Covid controls in China have tightened in the last two weeks after more cities reported virus outbreaks. […]
Read More
New Covid boosters aren’t better than old shots at neutralizing omicron BA.5, early studies find
The new COVID-19 booster which includes protection for Omicron at AltaMed Health Services in South Gate on Thursday, October 6, 2022. Sarah Reingewirtz | MediaNews Group | Los Angeles Daily News via Getty Images Two studies are raising doubts about whether the new omicron BA.5 booster really will offer better protection against Covid than the […]
Read More
Maven Clinic, women and family-focused health startup, is booming in the post-Roe v. Wade world
Women account for half of consumers, hold power over 80% of household financial decisions and make 70% of health-care-related decisions in their families – but their access to proper health care often comes up short. Especially in the post-Roe world, women are increasingly turning to their employers for proper health-care benefits for themselves and their […]
Read More